BioNexus Gene Lab Corp. (NASDAQ:BGLC – Get Free Report) saw a large growth in short interest in March. As of March 31st, there was short interest totalling 43,400 shares, a growth of 115.9% from the March 15th total of 20,100 shares. Currently, 0.6% of the shares of the stock are sold short. Based on an […]